Leading Growth Driver in the Cardiac Valve Market in 2025: Cardiac Valve Market Expansion Addressing The Growing Burden Of Heart-Related Ailments Driver's Influence

Which drivers are expected to have the greatest impact on the over the cardiac valve market's growth?
The escalation in cardiovascular ailments is anticipated to stimulate the progression of the cardiac valve industry. Cardiovascular disease's frequency has steadily risen due to elements like smoking, obesity, inadequate physical exercise, and cumulative stress on the cardiovascular structure. Fatty plaques accumulating in the arteries are the primary cause for coronary artery disease. This steady upsurge in heart-related disorders has heightened the necessity for cardiac valves needed to address heart valve issues. For instance, the World Health Organization, a specialized division of the United Nations based in Switzerland, reported in September 2023 that there were 41 million deaths globally, constituting 74% of total deaths caused by non-communicable diseases (NCDs) or chronic illnesses each year. The report detailed 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths due to diabetes. Thus, the escalating occurrence of cardiovascular diseases will spur the growth of the cardiac valve market.

Get Your Cardiac Valve Market Report Here:
https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report

What is the future CAGR of the cardiac valve market, and how will it impact industry expansion?
The market size for cardiac valves has seen significant expansion recently. The estimated growth exhibits an increase from $10.89 billion in 2024 to $12.48 billion by 2025, a compound annual growth rate (CAGR) of 14.6%. Factors contributing to the growth during the historical period include an aging population leading to increased instances of valvular heart disease, a rise in risk factors like obesity and hypertension, enhancements in diagnostic and imaging techniques for valve diseases, heart health and valve disease awareness programs, and the evolution of minimally invasive and transcatheter valve operations.

The market for cardiac valves is projected to experience substantial growth in the upcoming years, with an anticipated value of $21.26 billion by 2029, boasting a compound annual growth rate (CAGR) of 14.2%. Numerous factors can be associated with this expected growth during the forecast period, including the escalating demand for bioengineered and tissue-engineered heart valves, an aging global population, and the urgency for treatment options for valve disease. Other contributing elements include the increase in telemedicine and remote patient monitoring for valve patients, advances in surgical methodologies, and the adoption of robotics for valve procedures as well as the adoption of 3D printing for crafting personalized heart valves. Key trends anticipated during this period entail progress in valve replacement and repair methodologies, the application of artificial intelligence for valve disease diagnosis and treatment planning, increased usage of 3D printing for custom heart valve fabrication, and improved surgical strategies and robotics-aided valve procedures.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7753&type=smp

What are the most significant trends transforming the cardiac valve market today?
Advancements in cardiac valve technology are emerging as a significant trend in the cardiac valve market. As technology advances, it is creating less invasive therapies for heart disease. Major firms within the cardiac valve market are focusing on technologies such as neochordae implantation, annuloplasty ring, and robotic surgery to bolster their market presence. These revolutionary technologies assist in safeguarding patients against grave conditions like heart stroke and cardiac arrest. For example, Edwards, a US-based medical tech company, introduced the Sapien 3 Ultra Resilia transcatheter heart valve with anti-calcification technology in September 2022. This technology was engineered to permanently block calcium binding sites in bioprosthetic valves.

Which key market segments comprise the cardiac valve market and drive its revenue growth?
The cardiac valve market covered in this report is segmented -

1) By Type: Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves, Other Types
2) By Position: Aortic Valve, Mitral Valve, Other Positions
3) By Treatment: Cardiac Valve Repair, Cardiac Valve Replacement
4) By End-Users: Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users

Subsegments:
1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine), Homograft Valves
2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Implantation (TAVI) Valves, Transcatheter Mitral Valve Repair Valves
3) By Mechanical Heart Valves: Tilting Disc Valves, Bileaflet Valves, Caged Ball Valves
4) By Other Types: Conduits, Stented vs. Stentless Valves

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7753

What regions are at the forefront of cardiac valve market expansion?
North America was the largest region in the cardiac valve market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the leading players fueling growth in the cardiac valve market?
Major companies operating in the cardiac valve market include Abbott Laboratories, Colibri Heart Valve LLC, TTK HealthCare Limited, Artivion Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation, Jenavalve Technology Inc., CryoLife Inc., Lepu Medical Technology Co. Ltd., Braile Biomedical, Sorin Group, Micro Interventional Devices Inc., Medtronic Inc., Lepu Medical Technology, Edward Lifesciences Corporation, Xeltis AG, Meril Life Sciences Pvt. Ltd., Auto Tissue Berlin GmbH, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=7753&type=smp

What Is Covered In The Cardiac Valve Global Market Report?

•Market Size Forecast: Examine the cardiac valve market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the cardiac valve market for a structured understanding.
•Key Players Overview: Analyze major players in the cardiac valve market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the cardiac valve market.
•Segment Contributions: Evaluate how different segments drive overall growth in the cardiac valve market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the cardiac valve market.
•Industry Challenges: Identify potential risks and obstacles affecting the cardiac valve market.
•Competitive Landscape: Review strategic developments in the cardiac valve market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.